A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 38/10 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2619654
The present application relates to compositions of extracellular matrix (ECM) antagonists and their use in methods for treating angiogenic-dependent conditions. The ECM antagonists can bind the same or different ECM component. The present application also relates to compositions of ECM antagonists and cancer therapies and their use in methods for preventing, treating or managing angiogenic- dependent conditions such as cancer.
L'invention concerne des compositions d'antagonistes de la matrice extracellulaire (ECM) et l'utilisation de celles-ci pour traiter des états pathologiques dépendant de l'angiogenèse. Les antagonistes de l'ECM peuvent se lier à un seul et même composant de l'ECM ou à des composants différents. L'invention concerne aussi des compositions d'antagonistes de l'ECM et des traitements anticancéreux, et leur utilisation pour prévenir, traiter ou régulariser des états pathologiques dépendant de l'angiogenèse tels que le cancer.
Brooks Peter C.
Freimark Bruce
Van Epps Dennis
Cell Matrix
Smart & Biggar
LandOfFree
Combination therapies for inhibiting integrin-extracellular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapies for inhibiting integrin-extracellular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapies for inhibiting integrin-extracellular... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1796127